Detalles de la búsqueda
1.
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund.
Tumori
; 110(3): 168-173, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38372045
2.
Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer: meta-analytical estimation and implications for therapeutic strategies.
Cancer
; 118(6): 1523-32, 2012 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22009364
3.
Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: meta-analysis of randomized trials.
BMC Cancer
; 10: 675, 2010 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-21143897
4.
Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
Lung Cancer
; 63(1): 50-7, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18565615
5.
Trastuzumab plus weekly epirubicin and paclitaxel for locally advanced and metastatic breast cancer: preliminary results of a feasibility-phase II study aimed at cardiotoxicity.
Anticancer Drugs
; 20(2): 109-14, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19209027
6.
Cetuximab for metastatic colorectal cancer.
N Engl J Med
; 361(1): 95-6; author reply 96-7, 2009 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-19579280
7.
Peripheral neurotoxicity of weekly paclitaxel chemotherapy: a schedule or a dose issue?
Clin Breast Cancer
; 7(7): 550-4, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17509163
8.
Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research.
Expert Opin Biol Ther
; 17(4): 497-506, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28133971
9.
Early switch with aromatase inhibitors as adjuvant hormonal therapy for postmenopausal breast cancer: pooled-analysis of 8794 patients.
Cancer Treat Rev
; 32(5): 325-32, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16766125
10.
Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials.
Cancer Treat Rev
; 32(8): 583-7, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16919884
11.
Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants?
Chest
; 130(6): 1808-16, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17167001
12.
Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer.
Transl Lung Cancer Res
; 4(6): 704-12, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26798579
13.
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.
PLoS One
; 10(6): e0130142, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26086854
14.
EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy.
J Thorac Oncol
; 7(4): 672-80, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22425916
15.
Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
J Clin Oncol
; 23(28): 7248-50; author reply 7250, 2005 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16192623
16.
Emerging pathways and future targets for the molecular therapy of pancreatic cancer.
Expert Opin Ther Targets
; 15(10): 1183-96, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21819318
17.
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials.
J Exp Clin Cancer Res
; 30: 54, 2011 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-21569417
18.
Early recurrence risk: aromatase inhibitors versus tamoxifen.
Expert Rev Anticancer Ther
; 10(8): 1239-53, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20735310
19.
Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials.
J Exp Clin Cancer Res
; 29: 58, 2010 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-20504361
20.
Targeting targeted agents: open issues for clinical trial design.
J Exp Clin Cancer Res
; 28: 66, 2009 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-19463172